These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 7756103)

  • 1. CYP3A4 and CYP2A6 activities marked by the metabolism of lignocaine and coumarin in patients with liver and kidney diseases and epileptic patients.
    Sotaniemi EA; Rautio A; Bäckstrom M; Arvela P; Pelkonen O
    Br J Clin Pharmacol; 1995 Jan; 39(1):71-6. PubMed ID: 7756103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Age and CYP3A4 and CYP2A6 activities marked by the metabolism of lignocaine and coumarin in man.
    Sotaniemi EA; Lumme P; Arvela P; Rautio A
    Therapie; 1996; 51(4):363-6. PubMed ID: 8953808
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis A impairs the function of human hepatic CYP2A6 in vivo.
    Pasanen M; Rannala Z; Tooming A; Sotaniemi EA; Pelkonen O; Rautio A
    Toxicology; 1997 Dec; 123(3):177-84. PubMed ID: 9355936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determination of coumarin metabolism in Turkish population.
    Cok I; Aygün Kocabaş N; Cholerton S; Karakaya AE; Sardaş S
    Hum Exp Toxicol; 2001 Apr; 20(4):179-84. PubMed ID: 11393269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interindividual variability of coumarin 7-hydroxylation in healthy volunteers.
    Rautio A; Kraul H; Kojo A; Salmela E; Pelkonen O
    Pharmacogenetics; 1992 Oct; 2(5):227-33. PubMed ID: 1306122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The lignocaine metabolite (MEGX) liver function test and P-450 induction in humans.
    Reichel C; Skodra T; Nacke A; Spengler U; Sauerbruch T
    Br J Clin Pharmacol; 1998 Dec; 46(6):535-9. PubMed ID: 9862241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Consumption of watercress fails to alter coumarin metabolism in humans.
    Murphy SE; Johnson LM; Losey LM; Carmella SG; Hecht SS
    Drug Metab Dispos; 2001 Jun; 29(6):786-8. PubMed ID: 11353744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single-dose methoxsalen effects on human cytochrome P-450 2A6 activity.
    Kharasch ED; Hankins DC; Taraday JK
    Drug Metab Dispos; 2000 Jan; 28(1):28-33. PubMed ID: 10611136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of coumarin 7-hydroxylation in man.
    Pelkonen O; Rautio A; Raunio H; Mäenpää J; Hakkola J
    J Cancer Res Clin Oncol; 1994; 120 Suppl():S30-1. PubMed ID: 8132700
    [No Abstract]   [Full Text] [Related]  

  • 10. CYP2A6: a human coumarin 7-hydroxylase.
    Pelkonen O; Rautio A; Raunio H; Pasanen M
    Toxicology; 2000 Apr; 144(1-3):139-47. PubMed ID: 10781881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single-dose disulfiram does not inhibit CYP2A6 activity.
    Kharasch ED; Hankins DC; Baxter PJ; Thummel KE
    Clin Pharmacol Ther; 1998 Jul; 64(1):39-45. PubMed ID: 9695717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Variability of coumarin 7- and 3-hydroxylation in a Jordanian population is suggestive of a functional polymorphism in cytochrome P450 CYP2A6.
    Hadidi H; Irshaid Y; Vågbø CB; Brunsvik A; Cholerton S; Zahlsen K; Idle JR
    Eur J Clin Pharmacol; 1998 Jul; 54(5):437-41. PubMed ID: 9754990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endotoxic shock alters the pharmacokinetics of lidocaine and monoethylglycinexylidide.
    McKindley DS; Boulet J; Sachdeva K; Wang P; Chichester C
    Shock; 2002 Mar; 17(3):199-204. PubMed ID: 11900338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of the CYP3A4 inhibitor erythromycin on the pharmacokinetics of lignocaine and its pharmacologically active metabolites in subjects with normal and impaired liver function.
    Orlando R; Piccoli P; De Martin S; Padrini R; Palatini P
    Br J Clin Pharmacol; 2003 Jan; 55(1):86-93. PubMed ID: 12534644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biotransformation of coumarin by rodent and human cytochromes P-450: metabolic basis of tissue-selective toxicity in olfactory mucosa of rats and mice.
    Zhuo X; Gu J; Zhang QY; Spink DC; Kaminsky LS; Ding X
    J Pharmacol Exp Ther; 1999 Feb; 288(2):463-71. PubMed ID: 9918546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Catalytic role of cytochrome P4502B6 in the N-demethylation of S-mephenytoin.
    Heyn H; White RB; Stevens JC
    Drug Metab Dispos; 1996 Sep; 24(9):948-54. PubMed ID: 8886603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of CYP1A2 and CYP3A4 in lidocaine N-deethylation and 3-hydroxylation in humans.
    Wang JS; Backman JT; Taavitsainen P; Neuvonen PJ; Kivistö KT
    Drug Metab Dispos; 2000 Aug; 28(8):959-65. PubMed ID: 10901707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of coumarin 7-hydroxylase activity in human liver microsomes.
    Draper AJ; Madan A; Parkinson A
    Arch Biochem Biophys; 1997 May; 341(1):47-61. PubMed ID: 9143352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of chronic exposure to low-level cadmium on renal tubular function and CYP2A6-mediated coumarin metabolism in healthy human subjects.
    Satarug S; Nishijo M; Ujjin P; Vanavanitkun Y; Baker JR; Moore MR
    Toxicol Lett; 2004 Mar; 148(3):187-97. PubMed ID: 15041069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of erythromycin and itraconazole on the pharmacokinetics of intravenous lignocaine.
    Isohanni MH; Neuvonen PJ; Palkama VJ; Olkkola KT
    Eur J Clin Pharmacol; 1998 Sep; 54(7):561-5. PubMed ID: 9832299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.